Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Bertrand

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
European Heart Journal|April 7, 2009
The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trialsJasper J Brugts, Toshiharu Ninomiya, Eric Boersma, et al.
The American Journal of Cardiology|September 22, 2010
Comparison of Bivalirudin versus Bivalirudin plus glycoprotein IIb/IIIa inhibitor versus heparin plus glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes having percutaneous intervention for narrowed saphenous vein aorto-coronary grafts (the ACUITY trial investigators)Dinesh Kumar, George Dangas, Roxana Mehran, et al.
Blood Pressure Monitoring|May 9, 2018
Diagnostic precision of mentally estimated home blood pressure meansFranck Olivier Ouattara, Mikhael Laskine, Nathalie Ng Cheong, et al.
Atherosclerosis|October 28, 2008
ACE inhibition with perindopril and biomarkers of atherosclerosis and thrombosis: results from the PERTINENT studyClaudio Ceconi, Kim M Fox, William J Remme, et al.
European Heart Journal|December 20, 2015
How can the European Society of Cardiology ensure compliance with ethical standards?Maarten L Simoons, Jean-Pierre Bassand, Jeroen Bax, et al.
The Canadian Journal of Cardiology|November 28, 2017
Comparison of Different Automated Office Blood Pressure Measurement Devices: Evidence of Nonequivalence and Clinical ImplicationsFélix Rinfret, Lyne Cloutier, Robert Wistaff, et al.
Circulation|June 12, 2002
Impact of different platelet glycoprotein IIb/IIIa receptor inhibitors among diabetic patients undergoing percutaneous coronary intervention: : Do Tirofiban and ReoPro Give Similar Efficacy Outcomes Trial (TARGET) 1-year follow-upMarco Roffi, David J Moliterno, Bernhard Meier, et al.
American Heart Journal|November 4, 2004
Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationaleGregg W Stone, Michel Bertrand, Antonio Colombo, et al.
The Canadian Journal of Cardiology|April 29, 2017
The Gap Between Manual and Automated Office Blood Pressure Measurements Results at a Hypertension ClinicFélix Rinfret, Lyne Cloutier, Hélène L'Archevêque, et al.
The American Journal of Cardiology|April 6, 2013
Development and validation of a cardiovascular risk assessment model in patients with established coronary artery diseaseLinda Battes, Rogier Barendse, Ewout W Steyerberg, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
European Heart Journal|April 7, 2009
The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trialsJasper J Brugts, Toshiharu Ninomiya, Eric Boersma, et al.
The American Journal of Cardiology|September 22, 2010
Comparison of Bivalirudin versus Bivalirudin plus glycoprotein IIb/IIIa inhibitor versus heparin plus glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes having percutaneous intervention for narrowed saphenous vein aorto-coronary grafts (the ACUITY trial investigators)Dinesh Kumar, George Dangas, Roxana Mehran, et al.
Blood Pressure Monitoring|May 9, 2018
Diagnostic precision of mentally estimated home blood pressure meansFranck Olivier Ouattara, Mikhael Laskine, Nathalie Ng Cheong, et al.
Atherosclerosis|October 28, 2008
ACE inhibition with perindopril and biomarkers of atherosclerosis and thrombosis: results from the PERTINENT studyClaudio Ceconi, Kim M Fox, William J Remme, et al.
European Heart Journal|December 20, 2015
How can the European Society of Cardiology ensure compliance with ethical standards?Maarten L Simoons, Jean-Pierre Bassand, Jeroen Bax, et al.
The Canadian Journal of Cardiology|November 28, 2017
Comparison of Different Automated Office Blood Pressure Measurement Devices: Evidence of Nonequivalence and Clinical ImplicationsFélix Rinfret, Lyne Cloutier, Robert Wistaff, et al.
Circulation|June 12, 2002
Impact of different platelet glycoprotein IIb/IIIa receptor inhibitors among diabetic patients undergoing percutaneous coronary intervention: : Do Tirofiban and ReoPro Give Similar Efficacy Outcomes Trial (TARGET) 1-year follow-upMarco Roffi, David J Moliterno, Bernhard Meier, et al.
American Heart Journal|November 4, 2004
Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationaleGregg W Stone, Michel Bertrand, Antonio Colombo, et al.
The Canadian Journal of Cardiology|April 29, 2017
The Gap Between Manual and Automated Office Blood Pressure Measurements Results at a Hypertension ClinicFélix Rinfret, Lyne Cloutier, Hélène L'Archevêque, et al.
The American Journal of Cardiology|April 6, 2013
Development and validation of a cardiovascular risk assessment model in patients with established coronary artery diseaseLinda Battes, Rogier Barendse, Ewout W Steyerberg, et al.
Pageof 5